Page 9 - Nucleus Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Six million Aussies from today will be able to make a GP appointment for a COVID-19 vaccine. See if your area is on the list.

The PM is not concerned about Europe’s move to pause the AstraZeneca vaccine, as the final analysis for the Novavax jab on order in Australia was revealed.

Health by Sue Dunlevy, National Health Editor 12th Mar 2021 6:31 AM Premium Content   A COVID-19 vaccine pill that could revolutionise the control of the pandemic is being trialled in a handful of Australians. Not only would it eliminate the need for a painful jab, it could be stored at room temperature making it easy to transport and no medical workforce would be needed to deliver it. Australian clinical trial company Nucleus Network is testing the safety of the vaccine for Canadian biotech company Symvivo and initial trial ...

The PM is not concerned about Europe’s move to pause the AstraZeneca vaccine, as the final analysis for the Novavax jab on order in Australia was revealed.

Recruiting for Phase 1 Clinical Trials During a Full Lockdown, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will discuss how Nucleus Network pivoted from the familiar transient participant pool to a local population during a severe lockdown and how it was able to leverage the new profile of medical research and clinical trials to generate earned media coverage. Attendees will learn about strategies that were implemented to rapidly retarget to a new audience and gain insight into the motivations of participants during this period. In this webinar,...